REINsMoEN et al., 1992 - Google Patents
DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG …REINsMoEN et al., 1992
- Document ID
- 13735943082506422155
- Author
- REINsMoEN N
- Bolman R
- Savik K
- Butters K
- Hertz M
- Publication year
- Publication venue
- Transplantation
External Links
Snippet
Previous studies have demonstrated that donor antigen-specific primed-lymphocyte-test (PLT) reactivity of bronchoalveolar lavage lymphocytes is strongly associated with acute pulmonary rejection and with obliterative bronchiolitis (OB); however, a systematic analysis …
- 210000004698 Lymphocytes 0 title abstract description 23
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
Publication | Publication Date | Title |
---|---|---|
REINsMoEN et al. | DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG TRANSPLANT RECIPIENTS1 | |
Semenzato et al. | Lung T cells in hypersensitivity pneumonitis: phenotypic and functional analyses. | |
Mayer et al. | Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. | |
Ligthart et al. | The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. | |
Ligthart et al. | Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. | |
Parhar et al. | Suppression of lymphocyte alloreactivity by early gestational human decidua: I. Characterization of suppressor cells and suppressor molecules | |
Reznik et al. | Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome | |
Rabellino et al. | Receptors for C3 and IgG on macrophage, neutrophil and eosinophil colony cells grown in vitro | |
McIntyre et al. | Trophoblast modulation of maternal allogeneic recognition. | |
Mojcik et al. | Characterization of RT6 bearing rat lymphocytes: I. Ontogeny of the RT6+ subset | |
Molajoni et al. | Mechanism of liver allograft rejection: the indirect recognition pathway | |
De Berardinis et al. | The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. | |
Hunt et al. | Expression of histocompatibility antigens, transferrin receptors, intermediate filaments, and alkaline phosphatase by in vitro cultured rat placental cells and rat placental cells in situ | |
Preffer et al. | Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+ 3+ subpopulation. | |
Bagnasco et al. | Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid | |
Pinto et al. | Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. | |
Lanzavecchia et al. | Human T cell lines with antigen specificity and helper activity | |
Becker et al. | Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines | |
Andrews et al. | The limited immunocompetence of thymocytes within murine thymic nurse cells | |
Ballas et al. | Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus. | |
Lazarovits et al. | CD7–T cells in rheumatoid arthritis | |
Garraud et al. | Effect of blood storage on lymphocyte subpopulations | |
Stevenson et al. | Characterization of purified cryopreserved human monocyte function in assays of superoxide production, accessory cell function, chemotaxis, and in fluorescent cell sorter analysis | |
Padovan et al. | Immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid Comparison of flow cytometric and immunocytochemical techniques: Comparison of flow cytometric and immunocytochemical techniques | |
Winter et al. | Distinct phenotypes of infiltrating cells during acute and chronic lung rejection in human heart-lung transplants |